基本説明
The strategies covered include magnetic, optical, microwave and neutron absorption techniques, nanocapsules for active agents, nanoparticles as active agents, and active and passive targeting, while, and more.
Description
(Table of content)
Chapter 1: Conventional chemotherapeutic drug nanoparticles for cancer treatment
Chapter 2: Nanoparticles for photodynamic therapy of cancer
Chapter 3: Nanoparticles for Neutron Capture Therapy of Cancer
Chapter 4: Nano vehicles and high molecular weight delivery agents for Boron Neutron capture therapy
Chapter 5: Local cancer therapy with magnetic drug targeting using magnetic nanoparticles
Chapter 6: Nanomaterials for controlled release of anticancer agents
Chapter 7: Critical analysis of cancer therapy using nanomaterials
Chapter 8: Nanoparticles for thermotherapy
Chapter 9: Ferromagnetic filled carbon nanotubes as novel and potential containers for anticancer treatment strategies
Chapter 10: Lyposomes, dendrimers and other nanoparticles for targeted delivery of anticancer agents - a comparative study
Chapter 11: Colloidal systems for the delivery of anticancer agents in breast cancers and multiple Myeloma
(Text)
This first comprehensive overview on nanotechnological approaches to cancer therapy brings together therapeutic oncology and nanotechnology, showing the various strategic approaches to selectively eliminating cancerous cells without damaging the surrounding healthy tissue. The strategies covered include magnetic, optical, microwave and neutron absorption techniques, nanocapsules for active agents, nanoparticles as active agents, and active and passive targeting, while also dealing with fundamental aspects of how nanoparticles cross biological barriers.A valuable single source gathering the many articles published in specialized journals often difficult to locate for members of the other disciplines involved.
(Author portrait)
Dr. Challa S. S. R. Kumar is Director of Nanofabrication and Nanomaterials at the Center for Advanced Microstructures and Devices at Louisiana State University in Baton Rouge, USA. He is also President and CEO of Magnano Technologies and has some years of industrial R&D experience working for Imperial Chemical Industries and United Breweries. His main research interests are the development of novel synthetic methods, including those based on microfluidic reactors, for the synthesis of multifunctional nanomaterials. Dr. Kumar is the winner of the 2006 Nano 50 Technology Award for his work in magnetic-based nanoparticles for cancer imaging and treatment. He is the editor and author of several books and journal articles, and a former editor of the Journal of Biomedical Nanotechnology.
